Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
| NCT number |
NCT05273424 |
| Other study ID # |
COHEBRA |
| Secondary ID |
|
| Status |
Enrolling by invitation |
| Phase |
|
| First received |
|
| Last updated |
|
| Start date |
June 1, 2017 |
| Est. completion date |
June 1, 2027 |
Study information
| Verified date |
February 2022 |
| Source |
Catholic University of Pelotas |
| Contact |
n/a |
| Is FDA regulated |
No |
| Health authority |
|
| Study type |
Observational
|
Clinical Trial Summary
Introduction: Chronic kidney disease (CKD) is characterized by progressive decrease in
glomerular filtration rate (GFR), eventually reaching the end-stage renal disease (ESRD)
requiring renal replacement therapy (RRT). The decrease in GFR is associated with a linear
increase in cardiovascular mortality. Dysfunction of the autonomic nervous system (ANS) has
been well documented in patients with CKD, especially in people with ESRD. The renal ischemia
causes both the excessive activation of the renin-angiotensin-aldosterone system (RAAS) by
increasing renin release, as sympathetic ANS, through the afferent sympathetic nerves. The
overactivated RAAS and sympathetic SNA feedback each other, which contributes to
cardiovascular disease (CVD) in CKD. Despite the involvement of these systems in the
pathogenesis of CVD in CKD, drugs that block the RAAS or sympathetic SNA have shown
heterogeneous effects in CVD in this population. A potential explanation is the genetic
heterogeneity, such as the polymorphism in the gene for angiotensin converting enzyme
(ACE).In addition, the inflammatory process associated with CKD is regarded as central player
in the general degenerative changes backing CKD on HD shorter survival, which in many aspects
is like accelerated aging. Skeletal muscles are also affected in a pattern like aging
sarcopenia, with loss of function and mass. Objectives: to evaluate the impact of ECA gene
polymorphism, HRV, body composition, functional capacity, muscle strength, inflammatory
factors and other potential predictors on the survival of patients with CKD treated by HD in
a single center in southern Brazil. Methodology: Prospective cohort study. The sample will
consist of adult patients with CKD on HD longer than 90 days. Sociodemographic and clinical
data is collected from clinical records. HRV analysis is performed using a Micromed@
electrocardiogram device® with a recording of the standard deviation of all normal intervals
(SDNN), square root of the mean of the squares of the differences between consecutive
intervals (RMSSD), low frequency band (LF) and high frequency (HF) after a midweek HD
session. The polymorphism of the ECA gene was evaluated by polymerase chain reaction method
in peripheral blood DNA sample. Muscle quality and thickness has been obtained by ultrasound.
Functional capacity by 6-minute walking test and muscle strength by dynamometer. The data
will be analyzed using Stata 15.0 statistical package.
Description:
Evaluation of HRV. HRV measurement was performed using an electrocardiographic device
(Wincardio@, Micromed). The registry was acquired for 20 min before, in the second hour, and
immediately after a midweek HD session. Patients were in a supine position and breathed
normally during the recording. Patients with unstable patterns of breath had their HRV
recording postponed. The electrocardiographic device transmitted the R-R interval record to
digital storage, which was subsequently analyzed in the time and frequency domains of HRV
through CardioSeries@ 2.4 software. In the time domain, RMSSD and SDNN were acquired. In the
frequency domain analysis, a tachogram was interpolated in a frequency of 4 Hertz and divided
into periods of 256 points with 50% overlap. These signals were submitted to spectral
analysis by fast Fourier transformation to obtain the total power of the spectrum. The LF
band, representing sympathetic modulation, was between 0.02 and 0.15 Hz. The HF band,
attributed to parasympathetic modulation, was between 0.15 and 0.40 Hz.
ACE gene typing. Blood samples were drawn and centrifugated. The leukocyte supernatant pellet
was extracted and stored. ACE polymorphism was typed by PCR for DD, ID, and II genotypes. It
used the following specific primers for DNA amplification: sense
5=-CTGGAGACCACTCCCATCCTTTCT-3= and antisense 5= GATGTGGCCATCACATTCGTAGA- 3=. Through these
primers, it was possible to detect allele deletion and insertion. A confirmatory PCR was done
for all samples with the DD genotype to increase the specificity of the genotyping using a
pair of specific primers for insertions, i.e., an allele I amplifier. These primers were as
follows: sense 5=-TGGGACCACAGCGCCCGCCACTAC-3= and antisense 5=-TCGCCAGCCCTACCATGCCCATAA-3=.
The temperature protocol was programed in the thermocycler beginning at 95°C for 5 min and
then 40 cycles of denaturation at 95°C for 45 s, annealing at 54°C for 1 min, and extension
at 72°C for 30 s each and then at 5 min at 72°C to finish uncompleted chains.
Hydration status assessment. The patient's hydration status was evaluated before and after
(up to 20 min) the studied HD session using a Body Composition Monitor (Fresenius), which
uses multifrequency bioimpedance spectroscopy to determine the electrical resistances of
total body water and extracellular water. Electrodes were attached to the hand and feet
opposite to vascular access, with the patient in a supine position, and the measurement was
done and stored in a digital format and analyzed with the Fluid Management Tool. The results
were provided as overhydration (in liters), which represents the excess of water above
reference levels according to the patient's sex and age.
Muscle thickness and echo intensity by ultrasound Patients were evaluated after one midweek
dialysis session. They initially were instructed to stand with the legs and ~20 cm apart. The
length of right thigh was measured from the superior iliac spine to the proximal border of
the patella. Right and left circumferences were assessed at the midpoint of the thighs. At
the same level on the anterior face of the thighs, skin was marked with a water-resistant
pen. The quadriceps thickness was measured with the probe over these points, perpendicular to
the long axis of the limb (cross-sectional image) and captured after proper visualization of
the bone surface. The image was stored in device's hard disk for each of the two sites.
The images were analyzed later using the software ImageJ (National Institute of Health, USA,
version 1.37) for both muscle thickness and echo intensity (EI). The thickness was measured
as the perpendicular distance between the point just above the apex of the femur surface and
the point just below the rectus femoris' superficial fascia obtained using the same software
with the length function. The measurements were registered in millimeters and posteriorly
converted to centimeters.
The EI analysis was performed after the selection of a record region that includes as much
muscle as possible while avoiding surrounding fascia. The EI was then calculated from the
selected region with gray-scale analysis using the standard histogram function and expressed
in values between 0 and 255 (0 = black; 255 = white) (Radaelli et al., 2013; Wilhelm et al.,
2014).
Functional capacity - six-minute walking test Functional capacity was measured using the
6-minute walk test (6MWT). This test is a submaximal effort test, affordable and easy to
perform, in addition to be well established as representative of functional capacity in frail
subjects. The 6-minute walk test shows a good correlation with the maximal oxygen uptake
measure. The result of 6MWT in meters was multiplied by 100 and divided by the predicted
distance for age. The result (percent of predicted distance walked by age) was used in
analysis.
Muscle strength assessment Evaluation of muscle strength was performed using the static
strength test of the legs, using a Crown® (Oswaldo Filizola Industry, São Paulo, Brazil)
dynamometer. The measurement was repeated after a 1-minute interval. The mean of the two
measurements was used in the analysis.
